Patient Dataset for: “Cachexia in Gynecologic Cancers: The Role of Biomarkers and Cachexia Index”

This dataset contains de-identified patient-level data used in the study titled “Cachexia in Gynecologic Cancers: The Role of Biomarkers and Cachexia Index.” he study was conducted to evaluate the prevalence of cachexia and the utility of the Cachexia Index (CXI) in women with gynecologic malignancies, particularly in the Indian population.Variables include demographic information, cancer type and stage, treatment details, biochemical markers, anthropometric measurements, and cachexia index components. The data were collected prospectively the All India Institute of Medical Sciences (AIIMS), New Delhi, India, from July 2022 to June 2024.The dataset is intended to support transparency and reproducibility of the findings and is shared in accordance with ethical and privacy guidelines. All patient identifiers have been removed.

本数据集收录了题为《妇科癌症恶病质：生物标志物与恶病质指数的作用》（Cachexia in Gynecologic Cancers: The Role of Biomarkers and Cachexia Index）的研究中所使用的去标识化（de-identified）患者级数据。本研究旨在评估妇科恶性肿瘤女性患者的恶病质（Cachexia）患病率，以及恶病质指数（Cachexia Index, CXI）的应用价值，研究重点聚焦于印度人群。数据集涵盖的变量包括人口统计学信息、癌症类型与分期、治疗细节、生物化学标志物、人体测量学指标以及恶病质指数各组成项。该数据的前瞻性采集工作于2022年7月至2024年6月间，在印度新德里全印度医学科学研究所（All India Institute of Medical Sciences, AIIMS）开展。本数据集旨在助力研究结果的透明化与可重复性，且严格遵循伦理与隐私规范进行共享；所有患者标识均已移除。